Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 03, 2021	Oct. 04, 2020
Operating activities:
Net income	$ 752,973	$ 347,526
Loss from discontinued operations and dispositions, net of income taxes	123	138
Income from continuing operations	753,096	347,664
Adjustments to reconcile net income from continuing operations to net cash provided by continuing operations:
Restructuring and other costs, net	13,018	11,075
Depreciation and amortization	232,935	182,521
Loss (Gain) on disposition of businesses and assets, net	(1,970)	886
Stock-based compensation	18,957	19,770
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	1,553	(8,807)
Amortization of deferred debt financing costs and accretion of discounts	3,224	2,559
Change in fair value of financial securities	(8,566)	0
Asset Impairment Charges	3,868	0
Amortization of acquired inventory revaluation	14,728	1,757
Changes in operating assets and liabilities which provided (used) cash, excluding effects from companies purchased and divested:
Accounts receivable, net	242,386	(67,695)
Inventories	6,316	(120,934)
Accounts payable	(37,002)	16,391
Accrued expenses and other	(167,385)	24,893
Net cash provided by operating activities	1,075,158	410,080
Investing activities:
Capital expenditures	(67,459)	(57,391)
Proceeds from surrender of life insurance policies	0	131
Payments to Acquire Investments	(19,130)	(9,559)
Proceeds from Divestiture of Businesses	1,460	2,423
Cash paid for acquisitions, net of cash, cash equivalents and restricted cash acquired	(3,967,678)	(3,702)
Net cash used in investing activities	(4,052,807)	(68,098)
Financing activities:
Payments of borrowings	1,191,125	515,210
Proceeds from borrowings	1,144,282	257,000
Proceeds from term loan	500,000	0
Repayments of Senior Debt	(339,605)	0
Proceeds from sale of senior debt	3,086,095	0
Payments of debt financing and equity issuance costs	(30,983)	0
Settlement of cash flow hedges	(1,459)	(2,089)
Net payments on other credit facilities	(12,731)	(8,124)
Payments for acquisition-related contingent consideration	0	(5,200)
Proceeds from issuance of common stock under stock plans	22,760	27,528
Purchases of common stock	(73,013)	(6,829)
Dividends paid	(23,539)	(23,381)
Net cash provided by (used in) financing activities	3,080,682	(276,305)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(16,584)	832
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalent	86,449	66,509
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at beginning of period	402,613	191,894
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at end of period	489,062	258,403
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	487,373	258,293
Restricted Cash, Current	1,689	110
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	489,062	258,403
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Equity issued for business combination, net of issuance costs	2,638,369	0
Contingent consideration incurred in business combination	34,131	0
Other liability incurred in business combination	$ 7,767	$ 0